Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: Case report and review of literature

21Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Roseomonas mucosa, as a Gram-negative coccobacilli, is an opportunistic pathogen that has rarely been reported in human infections. Here we describe a case of bacteremia in an infective endocarditis patient with systemic lupus erythematosus (SLE). Case presentations: A 44-year-old female patient with SLE suffered bacteremia caused by Roseomonas mucosa complicated with infective endocarditis (IE). The patient started on treatment with piperacillin-tazobactam and levofloxacin against Roseomonas mucosa, which was switched after 4 days to meropenem and amikacin for an additional 2 weeks. She had a favorable outcome with a 6-week course of intravenous antibiotic therapy. Discussion and conclusions: Roseomonas mucosa is rarely reported in IE patients; therefore, we report the case in order to improve our ability to identify this pathogen and expand the range of known bacterial causes of infective endocarditis.

Cite

CITATION STYLE

APA

Shao, S., Guo, X., Guo, P., Cui, Y., & Chen, Y. (2019, February 12). Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: Case report and review of literature. BMC Infectious Diseases. BioMed Central Ltd. https://doi.org/10.1186/s12879-019-3774-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free